The funding will support PoLoPo’s technology platform, starting with replicating ovalbumin, the protein found in egg white. The company says it expects to have prototypes in the coming 18 months, including protein-rich potato tubers and ovalbumin functional samples, as Jill Ettinger reports for Green Queen.
PoLoPo’s proprietary technology allows for proteins to be expressed in potatoes in a scalable, cost-effective way, which the company says can enable the food industry to meet its protein demands and nourish the world’s growing population; the egg protein market alone is valued at more than $26 billion, the company says.
Using its microbial tech, PoLoPo says its ovalbumin will be identical to chicken egg ovalbumin in terms of functionality, nutritional value, and protein sequence. The company says its potato-to-protein pathway offers commercial scalability since plants require relatively low investment to grow and are amenable to upscaling by common agricultural practices.
Source: Green Queen. Read the full story here
Photo: PoLoPo founders Maya Sapir-Mir (left) and Raya Liberman-Aloni (right). Credit Green Queen
Related: Company develops technology to produce egg protein in potatoes
